Articles Alert

SIMON SILVER Department of Microbiology & Immunology University of Illinois Chicago New York, San Francisco, and Los Angeles accounted for nearly half the new AIDS cases in early 1985. But the number of new cases in these cities has leveled off, and new cases here now represent 75 percent of the total. New AIDS cases among homosexuals are increasing slowly, but AIDS among intravenous drug users and AIDS associated with perinatal infection are increasing more rapidly. J.M. Karon, T.J. Donde

Written bySimon Silver
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

SIMON SILVER
Department of Microbiology & Immunology
University of Illinois
Chicago

New York, San Francisco, and Los Angeles accounted for nearly half the new AIDS cases in early 1985. But the number of new cases in these cities has leveled off, and new cases here now represent 75 percent of the total. New AIDS cases among homosexuals are increasing slowly, but AIDS among intravenous drug users and AIDS associated with perinatal infection are increasing more rapidly.

J.M. Karon, T.J. Dondero, Jr., and Public Health Service workshop of 12 members, "HIV prevalence estimates and AIDS case projections for the United States: Report based upon a workshop," Morbidity and Mortality Weekly Report, 39, 1-31, 30 November 1990. (Centers for Disease Control, Atlanta; National Institutes of Health, Bethesda, Md.; Walter Reed Army Institute of Research, Washington, D.C.)

A linear string of amino acids folds spontaneously (without outside help) into a predetermined three-dimensional protein ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies